Growing use of clinical registry data for post-market device surveillance
Thursday, September 26, 2013 - 21:30
in Health & Medicine
Signifying an increasing confidence in clinical outcomes registries, the U.S. Food and Drug Administration has approved expanded labeling for the Edwards SAPIEN Transcatheter Heart Valve, making the device available to a larger group of patients with aortic stenosis.